featured
Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 2018 Aug 24;[EPub Ahead of Print], JM Gaziano, C Brotons, R Coppolecchia, C Cricelli, H Darius, PB Gorelick, G Howard, TA Pearson, PM Rothwell, LM Ruilope, M Tendera, G TognoniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.